See up to 3 months of VSTM. The 7-day demo opens the 1M and 3M ranges and puts VSTM on your watchlist.
Start 7-day demoLatest VSTM insider trades
About Verastem, Inc. (VSTM)
Verastem, Inc. files with the SEC under CIK 0001526119 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
VSTM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 48,044 | $381K |
| Grant or award | 2 | 115,226 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VSTM insider transactions (Form 4)
4339 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dan Paterson - Officer | Grant or award | Common Stock | 106,893 footnote F1 | $0.00 | - | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 44,121 footnote F2 | $8.00 | $353K | |
| ||||||
| Daniel Calkins - Officer | Grant or award | Common Stock | 8,333 footnote F1 | $0.00 | - | |
| Daniel Calkins - Officer | Open-market sale | Common Stock | 2,566 footnote F2 | $8.00 | $21K | |
| ||||||
| Daniel Calkins - Officer | Open-market sale | Common Stock | 55 footnote F1 | $7.70 | $424 | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 1,302 footnote F1 | $5.81 | $8K | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 20,871 footnote F1 | $4.18 | $87K | |
| ||||||
| Daniel Calkins - Officer | Open-market sale | Common Stock | 4,032 footnote F1 | $4.18 | $17K | |
| Daniel Calkins - Officer | Open-market sale | Common Stock | 57 footnote F1 | $4.13 | $235 | |
| ||||||
 Michael P. Bailey - Director | Grant or award | Common Stock | 108,000 footnote F1,F2 | $0.00 | - | |
| ||||||
 Karin Anna Tollefson - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Brian M. Stuglik - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Eric K. Rowinsky - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
 Michelle Robertson - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Anil Kapur - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
 Paul A. Bunn - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| John Johnson - Director | Grant or award | Common Stock | 36,000 footnote F1 | $0.00 | - | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 806 footnote F1 | $5.82 | $5K | |
| ||||||
| Daniel Calkins - Officer | Grant or award | Common Stock | 57 footnote F1 | $5.74 | $327 | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 970 footnote F1 | $6.69 | $6K | |
| ||||||
| Daniel Calkins - Officer | Grant or award | Common Stock | 16,665 footnote F1 | $0.00 | - | |
| ||||||
| Dan Paterson - Officer | Grant or award | Common Stock | 213,785 footnote F1 | $0.00 | - | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 10,321 footnote F1 | $7.16 | $74K | |
| ||||||
| Daniel Calkins - Officer | Open-market sale | Common Stock | 5,039 footnote F1 | $7.16 | $36K | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.32 | $21K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.00 | $20K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.00 | $20K | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.32 | $21K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.79 | $22K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.39 | $21K | |
| ||||||
| Paul A. Bunn - Director | Open-market sale | Common Stock | 6,250 footnote F1 | $10.00 footnote F2 | $63K | |
| Paul A. Bunn - Director | Option exercise | Common Stock | 6,250 footnote F1 | $3.27 | $20K | |
| Paul A. Bunn - Director | Option exercise | Stock Options (right to buy) | 6,250 | $0.00 | - | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.00 | $20K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.00 | $20K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F1 | $10.00 | $20K | |
| ||||||
| Michael Kauffman - Director | Open-market sale | Common Stock | 8,550 footnote F1 | $10.00 footnote F2 | $86K | |
| ||||||
| Dan Paterson - Officer | Open-market sale | Common Stock | 1,299 footnote F1 | $9.35 | $12K | |
| Dan Paterson - Officer | Open-market sale | Common Stock | 2,000 footnote F2 | $10.00 | $20K | |
| ||||||
| Paul A. Bunn - Director | Open-market sale | Common Stock | 8,333 footnote F1 | $9.06 footnote F2 | $75K | |
| ||||||
| Daniel Calkins - Officer | Open-market sale | Common Stock | 57 | $9.08 | $518 | |
| Daniel Calkins - Officer | Open-market sale | Common Stock | 25 | $9.23 | $231 | |
| Brian M. Stuglik - Director | Open-market sale | Common Stock | 587 | $9.99 | $6K | |
Item 2.02, 5.02, 7.01, 8.01, 9.01
Item 1.01, 2.03, 7.01, 9.01
Item 2.02, 9.01
Item 7.01, 8.01, 9.01
Recent VSTM Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Dan Paterson | Officer, Director | 44,121 | $353K | View on EDGAR | |
| - | - | - |
VSTM insider trading FAQ
What is the latest insider trade for VSTM?
Verastem, Inc. (VSTM) had 4 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for VSTM runs to 39 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VSTM stock?
No insider purchases of VSTM were filed in the last 90 days.
How many insiders are selling VSTM stock?
4 insider sales of VSTM were filed in the last 90 days, totaling $381K.
Where can I see VSTM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VSTM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Dan Paterson view on EDGAR
- - Daniel Calkins view on EDGAR
- - Daniel Calkins view on EDGAR
- - Dan Paterson view on EDGAR
- - Dan Paterson view on EDGAR
- - Daniel Calkins view on EDGAR
- - Michael P. Bailey view on EDGAR
- - Karin Anna Tollefson view on EDGAR
- - Brian M. Stuglik view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where VSTM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VSTM with a 7-day demo
- VSTM on your watchlist
- Every VSTM Form 4 filing on record
- Up to 3 months of VSTM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
